IVF Success Rates by Age: What the Data Actually Shows

When couples consider in vitro fertilization, the question that matters most is also the one most difficult to answer simply: what are the actual chances of success? The published numbers vary widely depending on what is being measured, who is being measured, and how the data are framed. A clinic advertising 70 percent success rates and another reporting 35 percent may not be discussing different qualities of care; they may be discussing entirely different things, with different definitions of success applied to different populations.

The reality behind IVF success rates is that they reflect the intersection of biology, probability, laboratory technique, and individual variation. Among all the factors that influence outcomes, maternal age is the single most important. The decline in egg quality with age affects every step of the IVF process, from response to ovarian stimulation through embryo development to successful pregnancy and live birth. Yet age alone does not tell the full story. Two women of the same age can have substantially different outcomes based on ovarian reserve, the cause of infertility, prior reproductive history, and various other factors.

Understanding what IVF success rates actually mean, how they change with age, and what factors influence outcomes supports informed decisions for couples considering treatment. The data are clear in some areas and complex in others, but the patterns that emerge from large clinical registries provide a reliable foundation for thinking about expected outcomes.

This article explains how IVF success rates are measured, how they vary across age groups, why egg quality matters more than quantity for many outcomes, what factors influence individual chances, and how to interpret clinic statistics meaningfully.

For more on the IVF process broadly, see IVF: Process, Success Rates, and Risks.

What IVF Success Rates Actually Measure

Before discussing specific numbers, it is essential to understand what success rates actually measure, because different definitions produce dramatically different numbers.

Per-Cycle Success vs Cumulative Success

Per-cycle success rates measure outcomes from a single IVF cycle. A 40 percent per-cycle live birth rate means that 40 percent of cycles result in a live birth.

Cumulative success rates measure outcomes across multiple cycles. After two or three IVF cycles, cumulative live birth rates are higher than per-cycle rates because each successful cycle contributes to the cumulative total.

For couples evaluating treatment, both numbers matter. The per-cycle rate indicates the chance in any given attempt, while the cumulative rate indicates the chance over a course of treatment.

Pregnancy vs Live Birth

Pregnancy rates measure positive pregnancy tests, which include outcomes that may not result in a live birth. Some early pregnancies end in miscarriage or other losses.

Live birth rates measure the outcome that most couples are pursuing: a baby. Live birth rates are typically lower than pregnancy rates, with the gap reflecting miscarriage and other pregnancy losses.

For meaningful evaluation of IVF outcomes, live birth rates are typically the most useful measure. Pregnancy rates can overstate the practical likelihood of having a baby.

Per-Transfer vs Per-Retrieval

Per-transfer success rates measure outcomes per embryo transfer procedure. Per-retrieval rates measure outcomes per egg retrieval procedure. These differ because not every retrieval cycle results in a transfer.

For couples comparing options, per-retrieval rates often provide more meaningful information about overall outcomes from a complete cycle of treatment, including the possibility that no embryos suitable for transfer are produced.

Fresh vs Frozen Transfer

Fresh embryo transfers occur in the same cycle as egg retrieval. Frozen embryo transfers use embryos that were created in a prior cycle, frozen, and then thawed for transfer.

The two approaches can produce somewhat different success rates, with frozen transfers showing comparable or even slightly better outcomes than fresh transfers in many situations. The reasons include avoidance of the hormonal effects of stimulation on the uterine environment and selection benefits when only chromosomally normal embryos are transferred.

IVF Success Rates by Age

Maternal age is the single most important factor influencing IVF success, with rates declining progressively across the reproductive years. The patterns from large clinical registries provide reliable expected outcomes for different age groups, though individual results vary.

Under Age 35

For women under 35, IVF success rates are at their highest. Per-cycle live birth rates with the woman's own eggs are typically around 40 percent. The probability of having a baby from a single IVF cycle is meaningful but not certain.

The cumulative rates over multiple cycles are higher. Most couples in this age range who pursue IVF over multiple cycles achieve pregnancy, with cumulative live birth rates often exceeding 70 to 80 percent over three or four cycles for most clinical situations.

Ages 35 to 37

In women 35 to 37, per-cycle live birth rates remain reasonably high, typically around 30 to 35 percent. The decline from younger ages is measurable but modest.

The biology underlying this modest decline reflects gradual reduction in egg quality, with egg quantity often still relatively preserved. Most women in this age range respond well to ovarian stimulation and produce viable embryos.

Ages 38 to 40

The decline becomes more substantial in women 38 to 40. Per-cycle live birth rates typically drop to around 20 to 25 percent in this age range. The cumulative rates over multiple cycles remain meaningful but require more cycles than for younger women to reach favorable cumulative outcomes.

The biology in this age range reflects accelerating decline in egg quality. The proportion of embryos with chromosomal abnormalities increases substantially, contributing to higher rates of failed implantation and miscarriage.

Ages 41 to 42

In women 41 to 42, per-cycle live birth rates decline further to approximately 10 to 15 percent. The cumulative rates over multiple cycles still produce meaningful chances of pregnancy but with reduced effectiveness compared to younger ages.

Many women in this age range pursue specific strategies to optimize outcomes, including preimplantation genetic testing for chromosomal abnormalities, multiple embryos to identify the small proportion likely to be chromosomally normal, and various other approaches.

Ages 43 and Older

In women 43 and older, IVF success rates with the woman's own eggs decline substantially. Per-cycle live birth rates drop into the single digits, and even cumulative rates over multiple cycles produce limited probabilities.

The biology reflects severe age-related decline in egg quality. The proportion of embryos with chromosomal abnormalities is very high, often exceeding 80 percent. Even when embryos are produced, the chance of successful pregnancy from each is reduced.

For women in this age range, donor egg becomes a more reliable option for achieving pregnancy.

Donor Egg Cycles

Donor egg cycles produce success rates that reflect the age of the donor rather than the age of the recipient. Live birth rates with donor eggs are typically around 50 percent per transfer regardless of recipient age, providing a substantially higher probability of pregnancy than IVF with the woman's own eggs in older women.

For more on age and fertility broadly, see Female Fertility by Age.

Why Egg Quality Matters More Than Quantity

A common misconception about IVF and age is that the issue is primarily about egg quantity. The reality is more complex, with egg quality often mattering more than quantity for actual outcomes.

What Egg Quality Means

Egg quality refers to the genetic and cellular integrity of eggs. High-quality eggs have intact chromosomes, properly functioning cellular machinery, and the capacity to develop into healthy embryos. Lower-quality eggs have higher rates of chromosomal abnormalities and reduced developmental capacity.

The distinction matters because IVF success depends not just on producing eggs but on producing eggs that can develop into viable embryos and result in healthy pregnancies. A woman who produces 20 eggs of poor quality may have lower chances than a woman who produces 8 eggs of good quality.

How Quality Declines With Age

The decline in egg quality with age is driven primarily by chromosomal abnormalities. As eggs age, they accumulate changes that affect chromosome separation during the final stages of egg maturation. The resulting eggs more frequently have abnormal numbers of chromosomes, called aneuploidy.

The proportion of chromosomally abnormal eggs rises with age. By age 30, approximately 20 to 30 percent of eggs have chromosomal abnormalities. By age 40, the proportion exceeds 60 to 70 percent. By age 43, it often exceeds 80 percent.

Embryos created from chromosomally abnormal eggs typically fail at some stage. Some fail to develop in the laboratory. Some implant but result in early miscarriage. Some produce known chromosomal conditions. The cumulative effect on IVF outcomes is substantial.

Why Egg Quantity Is Less Predictive Than Expected

Markers of ovarian reserve, including AMH and antral follicle count, predict egg quantity reasonably well. They predict egg quality less reliably. A woman with high AMH may produce many eggs but, if she is older, those eggs may have poor quality. A woman with low AMH may produce few eggs but, if she is younger, those eggs may have good quality.

The implication for IVF is that age affects outcomes more profoundly than ovarian reserve markers suggest. Women in their 20s and early 30s with low AMH often have better IVF outcomes than expected, because their eggs, while fewer, retain good quality. Women in their 40s with normal or even high AMH often have worse outcomes than expected, because their eggs, while available in normal numbers, have substantially reduced quality.

Factors Beyond Age That Influence Success

While age is the most important factor, several others substantially influence IVF outcomes.

Cause of Infertility

The specific cause of fertility difficulty affects expected IVF outcomes.

Tubal factor infertility, where the only issue is blocked or damaged fallopian tubes, often produces favorable IVF outcomes because IVF directly bypasses the affected anatomy. Women with isolated tubal factor often have outcomes near the high end of expected ranges for their age.

Severe male factor infertility, particularly when ICSI is used, also often produces favorable outcomes. The technology can achieve fertilization with very low sperm numbers, making the limiting factor the female partner's age and other factors.

Endometriosis, particularly when severe, can affect outcomes through multiple mechanisms including effects on egg quality and the uterine environment.

Unexplained infertility produces outcomes typical for the woman's age, since the underlying cause is by definition unknown.

Prior Reproductive History

History of prior pregnancy, even if unsuccessful, often suggests favorable underlying biology. Women with prior live births who later face fertility issues sometimes have better IVF outcomes than expected for their age.

History of prior IVF cycles informs expected outcomes. Women who have failed multiple prior IVF cycles may have specific factors affecting outcomes that warrant further investigation.

Body Weight

Both significant overweight and underweight states can affect IVF outcomes. Body mass index in the healthy range is generally associated with better outcomes than significant deviation in either direction.

Lifestyle Factors

Smoking substantially reduces IVF success rates and increases miscarriage risk. Smoking cessation before treatment is strongly recommended.

Excessive alcohol use can affect outcomes, particularly when combined with other factors.

For more on these factors, see Lifestyle Factors That Affect Fertility.

Embryo Quality

Embryo quality, assessed in the laboratory, affects implantation rates. High-quality embryos have higher implantation rates than lower-quality ones. The factors that produce high-quality embryos include both egg quality and laboratory conditions during development.

Endometrial Receptivity

The uterine lining must be receptive to allow implantation. Various factors affect endometrial receptivity, including hormonal conditions, anatomical factors such as fibroids or polyps, and individual biological variation.

Number of Embryos Transferred

Transferring multiple embryos historically increased pregnancy rates per cycle but also increased multiple pregnancy rates. Modern IVF practice often involves single embryo transfer, with the trade-off of slightly lower per-transfer pregnancy rates balanced against substantially lower multiple pregnancy rates and associated complications.

Preimplantation Genetic Testing and Outcomes

Preimplantation genetic testing for aneuploidy (PGT-A) has become increasingly common in IVF, particularly for older women. The technology tests embryos for chromosomal abnormalities before transfer.

How PGT-A Affects Outcomes

PGT-A can improve outcomes per transfer by ensuring that only chromosomally normal embryos are transferred. The transfer of chromosomally normal embryos has higher implantation rates and lower miscarriage rates than transfer of randomly selected embryos.

For women whose embryos have high rates of chromosomal abnormalities, PGT-A can produce meaningful improvements in per-transfer outcomes.

Limitations of PGT-A

PGT-A does not increase the total number of viable embryos available. If a woman's eggs produce only a small proportion of chromosomally normal embryos, PGT-A identifies that small proportion but does not increase it. Some women complete IVF cycles in which no embryos are chromosomally normal, providing no embryos for transfer.

PGT-A also adds complexity, time, and cost to IVF cycles. The biopsy required for testing carries some risk to embryos, though the risk is generally low.

When PGT-A Is Most Useful

PGT-A is most useful for older women, in whom the proportion of chromosomally abnormal embryos is high. The selection benefit is greatest when many embryos are chromosomally abnormal, allowing identification of the smaller proportion that are viable.

For younger women, in whom most embryos are chromosomally normal, the benefit of PGT-A is more modest. The technology may still be useful for specific situations including recurrent miscarriage or known genetic conditions.

Cumulative Outcomes Over Multiple Cycles

While per-cycle success rates provide the chance for any given attempt, cumulative outcomes over multiple cycles often determine the overall trajectory.

Most couples who pursue IVF do so over multiple cycles. The cumulative chance of pregnancy increases with each additional cycle, though with diminishing returns over time.

• Women under 35: cumulative live birth rates after three or four cycles often exceed 70 to 80 percent.
• Women 38 to 40: cumulative rates over the same number of cycles are often 50 to 60 percent.
• Women 41 to 42: cumulative rates over three cycles are typically around 30 to 40 percent.
• Women 43 and older: cumulative rates remain limited even over multiple cycles.

The implications for couples planning treatment include considering the appropriate number of cycles based on age and other factors, understanding that single-cycle outcomes do not necessarily reflect cumulative possibilities, and being prepared for an extended treatment journey if needed.

How to Interpret Clinic Statistics

Clinic-reported statistics can vary substantially among centers, but the variations often reflect differences in patient populations rather than differences in care quality.

Patient Selection Effects

Clinics that primarily treat younger women with relatively favorable situations report higher success rates than clinics that treat broader populations including older women and complex cases. The difference in reported rates often reflects patient selection rather than treatment quality.

National Registries

In many countries, national registries collect IVF data with standardized definitions, allowing more meaningful comparison among clinics. The Society for Assisted Reproductive Technology in the United States, the Human Fertilisation and Embryology Authority in the United Kingdom, and similar organizations elsewhere provide standardized data.

For couples evaluating clinics, examining standardized data from national registries when available provides more meaningful comparison than clinic-promoted rates.

What to Look For

• Live birth rates per retrieval cycle, rather than per transfer, provide the most meaningful measure of overall outcomes.
• Age-specific rates allow comparison of expected outcomes for the relevant age group.
• Volume of cycles performed indicates clinic experience, with high-volume clinics generally maintaining well-developed laboratory and clinical capabilities.
• Single embryo transfer rates indicate adherence to modern practice that minimizes multiple pregnancy.

What Improves Individual Chances

For couples beginning IVF, several factors can be addressed to optimize chances within the constraints of their individual situation.

Lifestyle Optimization

Body weight optimization, smoking cessation, alcohol moderation, balanced nutrition, regular moderate exercise, and adequate sleep all support reproductive function during IVF.

For overweight individuals, even modest weight loss can improve outcomes. For couples in which either partner smokes, smoking cessation before treatment is strongly recommended given the substantial effects on outcomes.

Treatment of Underlying Conditions

Addressing thyroid disorders, diabetes, and other medical conditions before treatment supports better outcomes. For women with conditions specifically affecting reproduction, including endometriosis or fibroids, treatment as part of pre-IVF preparation may improve outcomes.

Considering Specific Strategies

For older women, specific strategies may improve outcomes including PGT-A to identify chromosomally normal embryos and consideration of donor egg if outcomes with the woman's own eggs are very limited.

When Donor Egg Becomes a Consideration

For couples in whom IVF outcomes with the woman's own eggs are very limited, donor egg becomes an option that can substantially improve chances.

The decision to consider donor egg involves substantial personal and emotional considerations. The biological and genetic relationship to a child differs when donor eggs are used. Common indications include repeated unsuccessful IVF cycles at advanced age, very low ovarian reserve in younger women, premature ovarian insufficiency, and genetic conditions the woman wishes not to pass to offspring.

Donor egg cycles produce success rates that reflect the donor's age, typically around 50 percent live birth per transfer, providing a substantially higher probability of pregnancy than IVF with the woman's own eggs in older women.

Setting Realistic Expectations

For couples considering IVF, setting realistic expectations supports better experiences regardless of the eventual outcome.

The per-cycle probability of success varies substantially with age and other factors. For younger women, the chance per cycle is meaningful but not certain. For older women, the chance per cycle may be modest, with success often requiring multiple cycles.

The cumulative probability over multiple cycles is often more favorable than single-cycle rates suggest. Individual variation is substantial — two women of the same age can have very different outcomes based on individual factors that may not be fully predictable in advance.

For couples beginning IVF, the practical approach involves understanding the expected outcomes for their specific situation, planning for an appropriate number of cycles based on age and other factors, addressing modifiable factors to optimize chances, and engaging with appropriate emotional support throughout.

For more on the IVF process, see IVF: Process, Success Rates, and Risks.

Conclusion

IVF success rates vary substantially with age and other factors, with maternal age being the single most important predictor of outcomes. The patterns from large clinical registries provide reliable expected outcomes for different age groups, though individual results vary based on multiple factors.

The decline in IVF success with age reflects primarily the decline in egg quality. Chromosomal abnormalities in eggs increase substantially with age, contributing to lower fertilization rates, lower implantation rates, and higher miscarriage rates. The biology underlying this decline cannot be fully overcome by any current technology, though approaches including PGT-A and donor egg can address specific aspects.

For couples considering IVF, understanding what success rates actually mean, how they vary with age, and what factors can be addressed supports informed decisions. The cumulative outcomes over multiple cycles often determine the overall trajectory more than per-cycle rates. Most couples who pursue IVF over multiple cycles eventually achieve their goals, though the path varies among couples and specific situations.

For more on broader fertility topics, see How to Get Pregnant: Complete Guide and Female Fertility by Age.

This content is for informational purposes only and does not constitute medical advice. Individuals should consult a qualified healthcare provider for diagnosis and treatment.